Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the use of Cereset Research to improve autonomic function in participants with symptoms of stress, anxiety, or insomnia.


Clinical Trial Description

The primary objective of this open label exploratory study is to evaluate the effect of CR to improve autonomic cardiovascular regulation in participants with symptoms of stress, anxiety, or insomnia. The secondary objective is to evaluate the effect of CR on a variety of self-reported symptom inventories. Tertiary objectives are to explore the impact of selected medications on outcomes associated with use of CR, the effect size in subgroups of participants who also report specific co-morbid symptoms or conditions of interest, and any unexpected challenges or barriers for working with the same. The latter includes those with TBI, PTSD, hypertension, hot flashes, chronic pain, or prior stroke. Methods: This will be a single site, open label, pilot clinical trial, enrolling people aged 11 or older, who have self-reported symptoms of stress, anxiety, or insomnia, and meet a threshold score on self-reported inventories. Up to 150 participants will be enrolled. Participants will receive between 6 and 12 sessions of audible tones echoing current brainwave activity (CR). Participants will continue their other current care throughout the study. There will be pre- and post-intervention data collection of physiological outcomes (BP, HR, and measures of autonomic cardiovascular regulation assessed by heart rate variability and baroreflex sensitivity), which will alse serve as the primary outcome. Secondary outcomes to be collected include symptom inventories for insomnia (Insomnia Severity Index, ISI; Pittsburgh Sleep Quality Index, PSQI), depression (Center for Epidemiological Studies- Depression Scale, CES-D), anxiety (Generalized Anxiety Disorder-7, GAD-7), stress (Perceived Stress Scale, PSS), traumatic stress (PTSD Checklist for civilians, PCL-C, or military, PCL-M), , and overall quality of life (QOLS). Other secondary outcome inventories will be collected for physical activity (International Physical Activity Questionnaire, IPAQ-SF), and physical activity satisfaction questions, as well. Participants who also self-report having specific co-morbid symptoms or conditions of interest may complete additional condition-specific outcome measures. All measures will be collected at an enrollment visit (V1), and the intervention will begin 0-14 days thereafter. Mean contrasts will be used to compare the changes in measures of autonomic cardiovascular regulation from V1 to V3, the primary outcome, as well as for secondary outcomes. Linear mixed models, which can accommodate within-subject correlations due to repeated assessments over time, will be used to generate point estimates for effect size along with 95% confidence intervals. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03777267
Study type Interventional
Source Wake Forest University Health Sciences
Contact Study Coordinator
Phone 336-716-9447
Email wfhirrem@wakehealth.edu
Status Recruiting
Phase N/A
Start date April 12, 2019
Completion date January 2026

See also
  Status Clinical Trial Phase
Terminated NCT03128086 - Weaning From Mechanical Ventilation in Neurological Patients N/A
Recruiting NCT04581577 - Perceptions of the Clinical and Psychosocial Impact of Covid-19 in Patients With Neuromuscular and Neurological Disorders
Active, not recruiting NCT05742087 - Neuropathy and Anti-GFAP Antibodies
Recruiting NCT05645003 - Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients N/A
Withdrawn NCT04377425 - COVID-19 Prevalence and Cognitive Deficits in Neurological Patients
Withdrawn NCT01898975 - A Gray Zone Approach to Stroke Volume Variation Derived From NICOM N/A
Active, not recruiting NCT03480581 - Impact of Reverse vs. Forward ICARE Training Interventions N/A
Completed NCT04061616 - Transcultural Validation of the Physical Activity Scale for Individuals With Physical Disabilities (PASIPD) in French: The PASIPD-Fr N/A
Recruiting NCT04706481 - Archival of Human Biological Samples in CU-Med Biobank
Completed NCT05169788 - Rehabilitation Through the Italian Version of the Teen Online Problem-Solving (TOPS) Program N/A
Recruiting NCT06450717 - IMPLEMENTATION OF A PILOT TELEREHABILITATION NETWORK IN PEDIATRIC PATIENTS WITH COMPLEX NEURODSABILITIES MedeaNeuroTelerehab-Net (MENTE.NET STUDY) N/A
Completed NCT03619642 - Reliability, Validity and Clinical Utility of a Robotic Assessment for Proprioception N/A
Recruiting NCT05526508 - Rebound Exercise in Neurological Disorders N/A
Recruiting NCT05086380 - Modulation of Sense of Agency With Non-invasive Brain Stimulation and Mindfulness-based Stress Reduction Therapy N/A
Recruiting NCT04866251 - Prevalence of Gag Reflex in Healthy Persons and Across Different Patient Groups and Its Relevance in Dysphagia Screening N/A
Not yet recruiting NCT05796037 - An Observational Study of Patients Living With Chronic Neurological Diseases
Completed NCT05097066 - Patterns and Outcomes of Neurosurgery in England Over a Five-year Period